Study Finds Roughly 4% Of Individuals With Neuropsychiatric Disorder Have Serious Adverse Event After Being Given Psychedelic As Part Of Research

Psychiatric News (9/5) reports, “About 4% of individuals with a neuropsychiatric disorder had a serious adverse event – including worsening depression, suicidal behavior, psychosis, or convulsions – after being given a ‘classic’ psychedelic as part of a research study, according to a meta-analysis that spanned some 75 years.” The research “identified no such adverse events among healthy participants; at the same time, tracking of such events should be improved, the study researchers wrote.” The findings were published in JAMA Psychiatry.